 The invariant chain is then broken down in stages by proteases called cathepsins, leaving only a small fragment known as CLIP which maintains blockage of the peptide binding cleft on the MHC molecule.A MHC class II-like structure, HLA-DM, facilitates CLIP removal and allows the binding of peptides with higher affinities.The stable class II MHC is then presented on the cell surface.